South Korea Nanomedicine Market Report by Nanomolecule Type (Nanoparticles, Nanoshells, Nanotubes, Nanodevices), Product (Therapeutics, Regenerative Medicine, In-Vitro Diagnostics, In-Vivo Diagnostics, Vaccines), Application (Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics, and Others), and Region 2026-2034

July 2026 | 118 pages | ID: S6F0C7304C0AEN
IMARC Group

Abstracts

South Korea nanomedicine market size reached USD 6.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 13.1 Billion by 2034, exhibiting a growth rate (CAGR) of 8.61% during 2026-2034. The increasing popularity of nanoparticles that can improve the solubility and bioavailability of poorly water-soluble drugs, thereby leading to better absorption and distribution of drugs within the body is driving the market.

Nanomedicine is a cutting-edge field that combines the principles of nanotechnology with medical science to revolutionize healthcare on a molecular scale. At this microscopic level, scientists manipulate materials and devices to interact with biological systems, offering unprecedented precision in diagnostics, treatment, and drug delivery. Nanoscale tools, such as nanoparticles and nanorobots, enable targeted therapy at the cellular and molecular levels, minimizing side effects and enhancing therapeutic efficacy. Diagnostic nanoprobes can detect diseases at their earliest stages, facilitating early intervention. Additionally, nanomedicine holds promise for personalized medicine, tailoring treatments to individual patients based on their unique molecular profiles. Despite its immense potential, nanomedicine also raises ethical and safety concerns, necessitating thorough research and regulatory frameworks to ensure responsible development and application in the realm of healthcare.

SOUTH KOREA NANOMEDICINE MARKET TRENDS:

The nanomedicine market in South Korea is propelled by several key drivers that collectively shape its dynamic market landscape. Firstly, advancements in nanotechnology have provided a robust foundation, enabling the precise manipulation of materials at the nanoscale. This, coupled with breakthroughs in biomedical research, has paved the way for the development of targeted drug delivery systems, a pivotal driver in the nanomedicine market. Moreover, the increasing incidence of chronic diseases, such as cancer and cardiovascular disorders, has intensified the demand for more effective and less invasive therapeutic interventions, fostering the growth of nanomedicine applications. In addition to this, collaborative efforts between academia, industry, and government institutions have played a pivotal role in driving nanomedicine forward. These partnerships facilitate knowledge exchange, funding opportunities, and streamlined regulatory pathways, fostering a conducive environment for R&D. Furthermore, rising investments from pharmaceutical companies keen on harnessing the potential of nanomedicine for drug discovery and development have injected substantial momentum into the market. The convergence of these factors not only propels the nanomedicine market in South Korea but also underscores its transformative potential in revolutionizing healthcare delivery, offering personalized treatments, and addressing unmet medical needs. As research continues to unravel the full spectrum of possibilities, the regional nanomedicine market is poised for sustained growth, promising a paradigm shift in the landscape of healthcare solutions.

SOUTH KOREA NANOMEDICINE MARKET SEGMENTATION:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country levels for 2026-2034. Our report has categorized the market based on nanomolecule type, product, and application.

Nanomolecule Type Insights:

• Nanoparticles
• Metal and Metal Oxide Nanoparticles
• Liposomes
• Polymers and Polymer Drug Conjugates
• Hydrogel Nanoparticles
• Dendrimers
• Inorganic Nanoparticles
• Nanoshells
• Nanotubes
• Nanodevices

The report has provided a detailed breakup and analysis of the market based on the nanomolecule type. This includes nanoparticles (metal and metal oxide nanoparticles, liposomes, polymers and polymer drug conjugates, hydrogel nanoparticles, dendrimers, and inorganic nanoparticles), nanoshells, nanotubes, and nanodevices.

Product Insights:

• Therapeutics
• Regenerative Medicine
• In-Vitro Diagnostics
• In-Vivo Diagnostics
• Vaccines

A detailed breakup and analysis of the market based on the product also been provided in the report. This includes therapeutics, regenerative medicine, in-vitro diagnostics, in-vivo diagnostics, and vaccines.

Application Insights:

• Clinical Oncology
• Infectious Diseases
• Clinical Cardiology
• Orthopedics
• Others

The report has provided a detailed breakup and analysis of the market based on the application. This includes clinical oncology, infectious diseases, clinical cardiology, orthopedics, and others.

Regional Insights:

• Seoul Capital Area
• Yeongnam (Southeastern Region)
• Honam (Southwestern Region)
• Hoseo (Central Region)
• Others

The report has also provided a comprehensive analysis of all the major regional markets, which include Seoul Capital Area, Yeongnam (Southeastern Region), Honam (Southwestern Region), Hoseo (Central Region), and Others.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

KEY QUESTIONS ANSWERED IN THIS REPORT
How has the South Korea nanomedicine market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the South Korea nanomedicine market?
What is the breakup of the South Korea nanomedicine market on the basis of nanomolecule type?
What is the breakup of the South Korea nanomedicine market on the basis of product?
What is the breakup of the South Korea nanomedicine market on the basis of application?
What are the various stages in the value chain of the South Korea nanomedicine market?
What are the key driving factors and challenges in the South Korea nanomedicine?
What is the structure of the South Korea nanomedicine market and who are the key players?
What is the degree of competition in the South Korea nanomedicine market?

Contents

1 PREFACE

2 SCOPE AND METHODOLOGY

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
  2.3.1 Primary Sources
  2.3.2 Secondary Sources
2.4 Market Estimation
  2.4.1 Bottom-Up Approach
  2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 EXECUTIVE SUMMARY

4 SOUTH KOREA NANOMEDICINE MARKET - INTRODUCTION

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 SOUTH KOREA NANOMEDICINE MARKET LANDSCAPE

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 SOUTH KOREA NANOMEDICINE MARKET - BREAKUP BY NANOMOLECULE TYPE

6.1 Nanoparticles
  6.1.1 Overview
  6.1.2 Historical and Current Market Trends (2020-2025)
  6.1.3 Market Segmentation
    6.1.3.1 Metal and Metal Oxide Nanoparticles
    6.1.3.2 Liposomes
    6.1.3.3 Polymers and Polymer Drug Conjugates
    6.1.3.4 Hydrogel Nanoparticles
    6.1.3.5 Dendrimers
    6.1.3.6 Inorganic Nanoparticles
  6.1.4 Market Forecast (2026-2034)
6.2 Nanoshells
  6.2.1 Overview
  6.2.2 Historical and Current Market Trends (2020-2025)
  6.2.3 Market Forecast (2026-2034)
6.3 Nanotubes
  6.3.1 Overview
  6.3.2 Historical and Current Market Trends (2020-2025)
  6.3.3 Market Forecast (2026-2034)
6.4 Nanodevices
  6.4.1 Overview
  6.4.2 Historical and Current Market Trends (2020-2025)
  6.4.3 Market Forecast (2026-2034)

7 SOUTH KOREA NANOMEDICINE MARKET - BREAKUP BY PRODUCT

7.1 Therapeutics
  7.1.1 Overview
  7.1.2 Historical and Current Market Trends (2020-2025)
  7.1.3 Market Forecast (2026-2034)
7.2 Regenerative Medicine
  7.2.1 Overview
  7.2.2 Historical and Current Market Trends (2020-2025)
  7.2.3 Market Forecast (2026-2034)
7.3 In-Vitro Diagnostics
  7.3.1 Overview
  7.3.2 Historical and Current Market Trends (2020-2025)
  7.3.3 Market Forecast (2026-2034)
7.4 In-Vivo Diagnostics
  7.4.1 Overview
  7.4.2 Historical and Current Market Trends (2020-2025)
  7.4.3 Market Forecast (2026-2034)
7.5 Vaccines
  7.5.1 Overview
  7.5.2 Historical and Current Market Trends (2020-2025)
  7.5.3 Market Forecast (2026-2034)

8 SOUTH KOREA NANOMEDICINE MARKET - BREAKUP BY APPLICATION

8.1 Clinical Oncology
  8.1.1 Overview
  8.1.2 Historical and Current Market Trends (2020-2025)
  8.1.3 Market Forecast (2026-2034)
8.2 Infectious Diseases
  8.2.1 Overview
  8.2.2 Historical and Current Market Trends (2020-2025)
  8.2.3 Market Forecast (2026-2034)
8.3 Clinical Cardiology
  8.3.1 Overview
  8.3.2 Historical and Current Market Trends (2020-2025)
  8.3.3 Market Forecast (2026-2034)
8.4 Orthopedics
  8.4.1 Overview
  8.4.2 Historical and Current Market Trends (2020-2025)
  8.4.3 Market Forecast (2026-2034)
8.5 Others
  8.5.1 Historical and Current Market Trends (2020-2025)
  8.5.2 Market Forecast (2026-2034)

9 SOUTH KOREA NANOMEDICINE MARKET – BREAKUP BY REGION

9.1 Seoul Capital Area
  9.1.1 Overview
  9.1.2 Historical and Current Market Trends (2020-2025)
  9.1.3 Market Breakup by Nanomolecule Type
  9.1.4 Market Breakup by Product
  9.1.5 Market Breakup by Application
  9.1.6 Key Players
  9.1.7 Market Forecast (2026-2034)
9.2 Yeongnam (Southeastern Region)
  9.2.1 Overview
  9.2.2 Historical and Current Market Trends (2020-2025)
  9.2.3 Market Breakup by Nanomolecule Type
  9.2.4 Market Breakup by Product
  9.2.5 Market Breakup by Application
  9.2.6 Key Players
  9.2.7 Market Forecast (2026-2034)
9.3 Honam (Southwestern Region)
  9.3.1 Overview
  9.3.2 Historical and Current Market Trends (2020-2025)
  9.3.3 Market Breakup by Nanomolecule Type
  9.3.4 Market Breakup by Product
  9.3.5 Market Breakup by Application
  9.3.6 Key Players
  9.3.7 Market Forecast (2026-2034)
9.4 Hoseo (Central Region)
  9.4.1 Overview
  9.4.2 Historical and Current Market Trends (2020-2025)
  9.4.3 Market Breakup by Nanomolecule Type
  9.4.4 Market Breakup by Product
  9.4.5 Market Breakup by Application
  9.4.6 Key Players
  9.4.7 Market Forecast (2026-2034)
9.5 Others
  9.5.1 Historical and Current Market Trends (2020-2025)
  9.5.2 Market Forecast (2026-2034)

10 SOUTH KOREA NANOMEDICINE MARKET – COMPETITIVE LANDSCAPE

10.1 Overview
10.2 Market Structure
10.3 Market Player Positioning
10.4 Top Winning Strategies
10.5 Competitive Dashboard
10.6 Company Evaluation Quadrant

11 PROFILES OF KEY PLAYERS

11.1 Company A
  11.1.1 Business Overview
  11.1.2 Product Portfolio
  11.1.3 Business Strategies
  11.1.4 SWOT Analysis
  11.1.5 Major News and Events
11.2 Company B
  11.2.1 Business Overview
  11.2.2 Product Portfolio
  11.2.3 Business Strategies
  11.2.4 SWOT Analysis
  11.2.5 Major News and Events
11.3 Company C
  11.3.1 Business Overview
  11.3.2 Product Portfolio
  11.3.3 Business Strategies
  11.3.4 SWOT Analysis
  11.3.5 Major News and Events
11.4 Company D
  11.4.1 Business Overview
  11.4.2 Product Portfolio
  11.4.3 Business Strategies
  11.4.4 SWOT Analysis
  11.4.5 Major News and Events
11.5 Company E
  11.5.1 Business Overview
  11.5.2 Product Portfolio
  11.5.3 Business Strategies
  11.5.4 SWOT Analysis
  11.5.5 Major News and Events

12 SOUTH KOREA NANOMEDICINE MARKET - INDUSTRY ANALYSIS

12.1 Drivers, Restraints, and Opportunities
  12.1.1 Overview
  12.1.2 Drivers
  12.1.3 Restraints
  12.1.4 Opportunities
12.2 Porters Five Forces Analysis
  12.2.1 Overview
  12.2.2 Bargaining Power of Buyers
  12.2.3 Bargaining Power of Suppliers
  12.2.4 Degree of Competition
  12.2.5 Threat of New Entrants
  12.2.6 Threat of Substitutes
12.3 Value Chain Analysis

13 APPENDIX